Figure 1From: Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts Distribution of SIA expenditure estimates by vaccine-preventable disease, 2004–2011 – cMYP data (N=142). Back to article page